StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by RelevantStockon Aug 24, 2020 4:17pm

162 Views

Post# 31447385

RE:RE:RE:Not a matter of if, but when.

Yes indeed I see this everywhere, unless a SP breaks out over a certain floor. I would have thought the volume bought by Echelon would have made it less easy to manipulate and rinse and repeat but it appears we will still be in that logic until the Q3 breakout.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta